taurine and ruthenium

taurine has been researched along with ruthenium in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alejo Perez Henarejos, S; Alexander Segato, C; Gammelgaard, B; Lambert, IH; Ruiz, J; Stürup, S; Støving Dam, C; Tsolakou, T; Yellol, GS	1
Deasy, K; Du, E; Hu, X; Mochizuki, T; Roy, S; Wang, P; Zhang, Y	1

Other Studies

2 other study(ies) available for taurine and ruthenium

Article	Year
In vitro characterization of a novel C,N-cyclometalated benzimidazole Ru(II) arene complex: stability, intracellular distribution and binding, effects on organic osmolyte homeostasis and induction of apoptosis. Metallomics : integrated biometal science, 2015, Volume: 7, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Female; Homeostasis; Humans; Mice; Ovarian Neoplasms; Ovary; Ruthenium; Taurine	2015
Taurine-modified Ru(ii)-complex targets cancerous brain cells for photodynamic therapy. Chemical communications (Cambridge, England), 2017, May-30, Volume: 53, Issue:44 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Death; Cell Line; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; PC12 Cells; Photochemotherapy; Photosensitizing Agents; Rats; Reactive Oxygen Species; Ruthenium; Taurine	2017

Article

Year

In vitro characterization of a novel C,N-cyclometalated benzimidazole Ru(II) arene complex: stability, intracellular distribution and binding, effects on organic osmolyte homeostasis and induction of apoptosis.

Metallomics : integrated biometal science, 2015, Volume: 7, Issue:5

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Female; Homeostasis; Humans; Mice; Ovarian Neoplasms; Ovary; Ruthenium; Taurine

2015

Taurine-modified Ru(ii)-complex targets cancerous brain cells for photodynamic therapy.

Chemical communications (Cambridge, England), 2017, May-30, Volume: 53, Issue:44

Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Death; Cell Line; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; PC12 Cells; Photochemotherapy; Photosensitizing Agents; Rats; Reactive Oxygen Species; Ruthenium; Taurine

2017